Inhibiting glucose transporter-1 and the PI3K/Akt pathway with apigenin, siRNA, LY294002 or wortmannin affects the radiosensitivity of laryngeal squamous cell carcinoma in vitro and in vivo
Background We first hypothesized that targeting glucose transporter-1 (GLUT-1) and the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway might improve the radiosensitivity of laryngeal cancer.
Laryngeal carcinoma,glucose transporter-1,PI3K/Akt pathway,radiosensitivity small interfering RNA,Ly294002,wortmannin
Shui-Hong Zhou Yang-Yang Bao Li-Bo Dai Zhong-Jie Lu Ya-Ping Huang Ting-Ting Wu
Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang Universit Department of Radiotherapy, The First Affiliated Hospital, College of Medicine, Zhejiang University, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospit
国内会议
浙江宁波
英文
274-275
2016-07-29(万方平台首次上网日期,不代表论文的发表时间)